Company / Inventory
GT Biopharma, Inc. Inventory History
FY2011-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$42.0K
FY2013
5-year range
-
FY2011-FY2013
Trend
-28.8%
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $12,000 to $42,000 over the past 2 years.
Based on SEC 10-K filings.
$42,000 in FY2013.
Improved from $12,000 to $42,000 over the past 2 years.
Inventory over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2013, inventory decreased 28.8% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2013 | $42.0K | -28.8% |
| FY2012 | $59.0K | +391.7% |
| FY2011 | $12.0K | - |
As of FY2013 · SEC 10-K · Updated Jun 24, 2026